Warning: Trying to access array offset on value of type bool in /var/www/vhosts/oncodaily.com/public_html/pub/themes/oncodailynews/single.php on line 25
Warning: Trying to access array offset on value of type bool in /var/www/vhosts/oncodaily.com/public_html/pub/themes/oncodailynews/single.php on line 26
Jan 5, 2024, 17:31
Summary of 10 new indications/approvals in Heme Malignancies by FDA Oncology in 2023 – Oncology Brothers
Quoting Oncology Brothers on X/Twitter:
“Summary of 10 new indications/approvals in Heme Malignancies (excluding CART) by FDA Oncology in 2023:
1. Zanubrutinib
2. Pirtobrutinib
3. Polatuzumab
4. Epcortimab
5. Glofitamab
6. Quizartinib
7. Talquetamab
8. Elranatamab
9. Ivosidenib”
Source: Oncology Brothers/X
Jul 26, 2024, 00:27